Hormone replacement therapy is used when human body is not able to produce enough hormones. It is used for the treatment for menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency conditions.
Rising incidences of hormonal imbalance disorders and increasing geriatric and neonatal population suffering from these diseases are expected to boost growth of the market. According to the statistics provided by the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause on a daily basis in U.S.
Grab Sample of this Report at: @
Market Dynamics
Increasing number of people suffering from hypogonadism and rising adoption of testosterone products in various economies is expected to propel overall growth of the market. According to the data published in the European Association of Urology Journal: 2017, testosterone prescription trends in the U.S. exhibited an increase between 1.8- and 4-fold over the last two decades (1997 – 2017). Moreover, from 2000 to 2011, there was a 4.3-fold increase in testosterone testing when compared to a 3.7-fold increase in prescriptions.
Rising number of generic versions of hormone replacement therapies by various manufacturers will drive growth of the market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017 to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator.
However, high cost associated with the replacement therapy and complex reimbursement scenario that causes excluding of the therapy from coverage by insurers, as it is a rare disease, hampers growth of the hormone replacement therapy market.
Key features of the study:
This report provides in-depth analysis of the hormone replacement therapy market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global hormone replacement therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global hormone replacement therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for hormone replacement therapy market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Hormone Replacement Therapy Market, By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Global Hormone Replacement Therapy Market, By Route of Administration:
Oral
Parenteral
Others
Global Hormone Replacement Therapy Market, By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
Global Hormone Replacement Therapy Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hormone Replacement Therapy Market, By Region:
North America
By Country:
U.S.
Canada
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Africa
By Country:
South Africa
Central Africa
North Africa
By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
By Route of Administration:
Oral
Parenteral
Others
By Application:
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Novartis AG*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Mylan NV
Merck KgaA
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Amgen, Inc.
Eli Lilly and Company
Get Exclusive Discount at: @
“*” marked represents similar segmentation in other categories in the respective section.
Industry Forecast Research 